Phytosphingosine & Sphingolipids
— A Ceramide alternative with higher bioavailability?
Phytosphingosines differ structurally from classic ceramides—and show altered epidermal integration in literature. What sphingolipid research means for barrier care and why costs are rising.
- Phytosphingosines vs. Ceramides: Hydroxyl groups, lamellar structure, and epidermal integration
- Phytoceramides, dihydrosphingosines, sphingomyelin, and glucosylceramides: four variations in the spectrum
- Rhythm-appropriate barrier care: What sphingolipid research means for day and night routines
- Frequently Asked Questions
Sphingolipids belong to the most structurally complex lipid classes in human skin—and as plant-analogous variants, phytosphingosines are the focus of growing scientific interest. Compared to classic ceramides, which have been considered the gold standard of barrier care for decades, phytosphingosines possess modified head-group chemistry, which is associated in the literature with altered interaction kinetics at the skin surface.
The question of whether phytosphingosines should be understood as a true ceramide alternative or rather as a complementary building block is relevant from both a pharmacological and formulation perspective. Recent studies indicate that their structural proximity to endogenous sphingoid bases may enable comparatively high bioavailability in the epidermal lipid matrix—an aspect that makes higher production costs interesting for both formulators and consumers.
Phytosphingosines vs. Ceramides: Hydroxyl groups, lamellar structure, and epidermal integration
To understand the special position of phytosphingosines, it is worth taking a brief look at the architecture of the skin barrier. The stratum corneum—the outermost horny layer—owes its protective function to a lamellar lipid structure in which ceramides, cholesterol, and free fatty acids are organized in a precise molar ratio. Ceramides form the quantitatively dominant backbone, maintain the lamellar organization, and enable the characteristic bilayer architecture.
Unlike sphingosines, phytosphingosines carry no trans-double bond, but instead have three hydroxyl groups at C4. This trihydroxylation significantly increases the hydrogen-bonding potential of the head group. In vitro models show stronger hydration of the polar head region, which is associated in the literature with altered packing density in the lipid lamella.
Phytosphingosines occur endogenously in the human epidermis and in sebaceous glands, albeit in significantly smaller amounts than ceramides. Their biosynthesis is closely linked to ceramide metabolism: phytosphingosines serve as direct precursors for phytoceramides. According to studies, topically applied phytosphingosines can be fed into this biosynthetic pathway, which may allow their efficacy to extend beyond simple occlusion.
Ceramides are high-molecular, amphiphilic compounds whose percutaneous penetration is complex to control from a formulation standpoint due to their chain length and polarity. Phytosphingosines have a slightly smaller molecular mass and show more favorable intercalation into epidermal lipid layers in penetration studies. Increased bioavailability does not automatically mean stronger efficacy—the decisive factor is whether the molecule is present in the right location in the right conformation.
Phytoceramides, dihydrosphingosines, sphingomyelin, and glucosylceramides: four variations in the spectrum
Phytosphingosines are not simple ceramide surrogates—they act in sphingolipid metabolism as multifunctional precursors with their own activity. Their increased bioavailability compared to high-molecular ceramides can be relevant in formulation, but it requires precise chain-length and carrier selection. In the ceramide context of barrier science, they are increasingly understood not as a replacement, but as a strategic supplement.
Rhythm-appropriate barrier care: What sphingolipid research means for day and night routines
- Lipid-rich formulations with defined ceramide and sphingolipid fractions in physiological ratios
- Gentle cleansing to maintain the endogenous lipid film – barrier-conscious cleansing
- Night care with occlusive oil components to support the nocturnal regeneration cycle
- Frequent use of high-percentage acid exfoliants without subsequent lipid restitution
- Formulations with a high alcohol content that can destabilize the sphingolipid lamellar framework
- Low-humidity ambient air without compensatory moisturizing care (cabin air effect)
The rhythm-based care logic of NATURFACTOR® intervenes exactly where the chronobiology of the barrier suggests: day and night differ significantly in their epidermal renewal rates—an aspect that Chrono-Barrier Skin Science™ uses as a conceptual basis. The Porcelain Skin Serum accompanies the morning phase with pullulan, two forms of hyaluronic acid, Kigelia extract with bioactive flavonoids, amino-acid-based active ingredients, functional silk polypeptides, and licorice root extract—geared toward moisture retention, barrier function, and skin structure throughout the day. For the night, the routine logic utilizes the Blue Crystal Drops facial oil with bioactive phytosterols, Vitamin C, bisabolol, and essential oils from blue lotus and blue tansy—for nocturnal regeneration, antioxidant protection, and a protective care film. Both products are available as a coordinated system, also as The Perfect Duo.
For specific skin concerns—such as persistent irritation, chronic barrier damage, or suspected ceramide synthesis disorders in the context of atopic diseases—a specialist medical opinion should be obtained.
Frequently Asked Questions
Are phytosphingosines really more effective than classic ceramides?
"More effective" is not the precise term here: phytosphingosines and classic ceramides act through partially different mechanisms. Phytosphingosines show more favorable intercalation into lipid layers in penetration studies, but they cannot fully replace the unique lamellar structure functions of long-chain ceramides. Literature tends to speak of a synergistic rather than a substitutive relationship.
Why are phytosphingosines more expensive than ceramides?
The production of phytosphingosines in cosmetic-grade purity requires elaborate fermentation or extraction processes—often from yeasts such as Pichia ciferrii or plant sources. The purification to formulation-relevant quality and the assurance of defined chain-length distributions contribute significantly to the costs. Due to more established production processes, certain ceramide fractions are more cost-effectively scalable.
Can phytosphingosines completely replace ceramides in barrier care?
Based on current research: likely not completely. Ceramides—especially long-chain acyl-ceramides like CER EOS—take on specific functions in the covalent bonding to corneocyte envelope proteins that phytosphingosines do not cover structurally. However, as a functional supplement or as a precursor in the biosynthetic cascade, phytosphingosines are well-documented. A combination of both classes is currently considered a formulationally advantageous approach.
For which skin types are sphingolipid-rich formulations particularly relevant?
In dermatological literature, sphingolipid deficiencies are described primarily in atopic dermatitis, dry and lipid-depleted skin, as well as photodamaged skin. Mature skin also shows age-related altered sphingomyelinase activity and thus altered ceramide generation from precursors. A universal recommendation cannot be derived from this—the decisive factor is the individual barrier situation, which is best assessed by a dermatologist.
- Bouwstra, J.A. & Ponec, M. (2006). The skin barrier in healthy and diseased state. Biochimica et Biophysica Acta, 1758(12), 2080–2095.
- Feingold, K.R. & Elias, P.M. (2014). Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochimica et Biophysica Acta, 1841(3), 280–294.
- Rabionet, M., Gorgas, K. & Sandhoff, R. (2014). Ceramide synthesis in the epidermis. Biochimica et Biophysica Acta, 1841(3), 422–434.
- Uchida, Y. & Holleran, W.M. (2008). Omega-O-acylceramide, a lipid essential for mammalian survival. Journal of Dermatological Science, 51(2), 77–87.
- Arikawa, J., Ishibashi, M., Kawashima, M., Takagi, Y., Ichikawa, Y. & Imokawa, G. (2002). Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. Journal of Investigative Dermatology, 119(2), 433–439.
This article is for informational purposes only and does not constitute medical advice. For specific skin concerns, we recommend seeing a dermatologist.
